1. Home
  2. MNTK vs EDIT Comparison

MNTK vs EDIT Comparison

Compare MNTK & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montauk Renewables Inc.

MNTK

Montauk Renewables Inc.

HOLD

Current Price

$1.11

Market Cap

194.2M

Sector

Utilities

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.32

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNTK
EDIT
Founded
1980
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.2M
206.0M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
MNTK
EDIT
Price
$1.11
$2.32
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$3.33
$4.92
AVG Volume (30 Days)
265.7K
1.6M
Earning Date
03-11-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.50
EPS
0.01
N/A
Revenue
$176,382,000.00
$31,937,000.00
Revenue This Year
$17.70
N/A
Revenue Next Year
$16.52
N/A
P/E Ratio
$122.80
N/A
Revenue Growth
0.37
132.64
52 Week Low
$1.18
$0.91
52 Week High
$2.78
$4.54

Technical Indicators

Market Signals
Indicator
MNTK
EDIT
Relative Strength Index (RSI) 26.73 53.26
Support Level N/A $1.84
Resistance Level $2.07 $2.36
Average True Range (ATR) 0.12 0.18
MACD -0.03 0.00
Stochastic Oscillator 0.92 52.91

Price Performance

Historical Comparison
MNTK
EDIT

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: